InvestorsHub Logo
Followers 0
Posts 5
Boards Moderated 0
Alias Born 02/23/2020

Re: None

Saturday, 06/10/2023 12:00:01 AM

Saturday, June 10, 2023 12:00:01 AM

Post# of 52001
"I asked bard Google's version of chatgpt about $SBES and Soleil Pharma. This is the reply: South Beach Spirits, Inc. (SBES) announced on March 1, 2022 that it had entered into an agreement and plan of merger with Soleil Pharma, Inc. (Soleil). The merger is expected to close in the first half of 2023.

Under the terms of the agreement, SBES shareholders will receive 0.1 shares of Soleil common stock for each share of SBES common stock they hold. Soleil will become a wholly-owned subsidiary of SBES upon completion of the merger.

The merger is expected to provide SBES with a number of benefits, including:

Increased scale and reach: Soleil has a strong presence in the Canadian market, which will allow SBES to expand its distribution network and reach a wider range of customers.

Improved profitability: Soleil is a profitable company, which will help SBES to improve its own profitability.

Synergies: The two companies have complementary product portfolios, which will allow them to generate synergies through the integration of their operations.

The merger is subject to the approval of SBES shareholders and certain regulatory approvals."